Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches
Journal of Clinical Medicine · 31.07.2023 · 12 (15) · 5050
DOI: 10.3390/jcm12155050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 31.07.2023. Verfasst von Christian Baumeier und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, 12203 Berlin, Germany. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Investitionsbank Berlin, Federal Ministry of Economic Affairs and Climate Action Germany, Investitionsbank Berlin/co-funded by EFRE.
Abstract (Originalsprache)
The diagnosis and specific and causal treatment of myocarditis and inflammatory cardiomyopathy remain a major clinical challenge. Despite the rapid development of new imaging techniques, endomyocardial biopsies remain the gold standard for accurate diagnosis of inflammatory myocardial disease. With the introduction and continued development of immunohistochemical inflammation diagnostics in combination with viral nucleic acid testing, myocarditis diagnostics have improved significantly since their introduction. Together with new technologies such as miRNA and gene expression profiling, quantification of specific immune cell markers, and determination of viral activity, diagnostic accuracy and patient prognosis will continue to improve in the future. In this review, we summarize the current knowledge on the pathogenesis and diagnosis of myocarditis and inflammatory cardiomyopathies and highlight future perspectives for more in-depth and specialized biopsy diagnostics and precision, personalized medicine approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiac Diagnostics and Therapy, IKDT GmbH, 12203 Berlin, Germany.
- Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany.
- Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Campus Virchow Klinikum, 13353 Berlin, Germany.
- German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, 10785 Berlin, Germany.
ORCID-Profile: Dominik Harms, Felicitas Escher
Förderung
- Investitionsbank Berlin
- Federal Ministry of Economic Affairs and Climate Action Germany
- Investitionsbank Berlin/co-funded by EFRE
Zitieren
APA
Baumeier, C., Harms, D., Aleshcheva, G., Gross, U., Escher, F., & Schultheiss, H. P. (2023). Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches. Journal of Clinical Medicine, 12(15), 5050. https://doi.org/10.3390/jcm12155050
Vancouver
Baumeier C, Harms D, Aleshcheva G, Gross U, Escher F, Schultheiss HP. Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches. Journal of Clinical Medicine. 2023;12(15):5050. doi:10.3390/jcm12155050
BibTeX
@article{Baumeier2023,
author = {Baumeier, Christian and Harms, Dominik and Aleshcheva, Ganna and Gross, Ulrich and Escher, Felicitas and Schultheiss, Heinz-Peter},
title = {Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {15},
pages = {5050},
doi = {10.3390/jcm12155050}
}
EUVIMED